- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06542068
Chatbot Effectiveness for Improving Mental Health and Reducing Stress in Nursing Students
Effectiveness of Using Chatbots for Nursing Students to Improve Mental Health and Reduce Stress During Internships.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Nursing students from the daytime four-year technical program at a university in southern Taiwan who have been scheduled for clinical internships.
Students who agree to participate in the study.
Exclusion Criteria:
Students who are only partially completing their internships (fragmented internship students).
Students who are unable to comply with the intervention measures.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Line Bot Assistance Group
During the internship, students will use the Line Bot as a support tool.The Line Bot aims to provide psychological health support and stress management resources, helping students cope with stress and challenges encountered during their clinical internships.
|
The chatbot is expected to provide self-help solutions and multiple counseling resources for stress and distress, options for face-to-face or online call requests, and a survey on mental health and stress. In terms of keywords, it will establish counseling response resources and methods for finding resources for special sensitive situations (e.g., feeling moody, suicidal, stressed, not wanting to intern, etc.). |
|
No Intervention: Control Group
This group will not receive assistance from the Line Bot chatbot.
These students will receive only the regular internship support and resources without the use of any technological assistance tools.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Brief Symptom Rating Scale
Time Frame: The students are interning for four weeks. A pre-test was conducted during the first week, and a post-test was administered at the end of the fourth week.
|
Five-point Likert-type scale of 0 to 4, with 0 being not at all and 4 being extremely.A total score on the BSRS-5 above 14, or a score of more than 1 on the additional suicide survey item, may indicate a severe mood disorder.
Scores between 10 and 14 may indicate moderate mood disorders, and those between 6 and 9 could indicate mild mood disorders.
|
The students are interning for four weeks. A pre-test was conducted during the first week, and a post-test was administered at the end of the fourth week.
|
|
Clinical Internship Stress Survey Form
Time Frame: The students are interning for four weeks. A pre-test was conducted during the first week, and a post-test was administered at the end of the fourth week.
|
Total of 24 questions are included in the survey, utilizing a four-point Likert-type scale ranging from 1 to 4. The total score on the scale falls between 24 and 96, with higher scores indicating increased stress levels during the clinical practicum.
|
The students are interning for four weeks. A pre-test was conducted during the first week, and a post-test was administered at the end of the fourth week.
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 113-470
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.